Biosensor VS CGM: What's The Real Difference?
If you've come across both "biosensor" and "CGM" while researching continuous glucose monitoring and wondered whether they mean the same thing, you're not alone.
From the product pages of medical-grade CGM brands like SIBIONICS to peer-reviewed studies indexed in PMC, these two terms frequently appear side by side — and are sometimes used interchangeably.
This article examines biosensor VS CGM from three angles: scientific definitions, underlying technology, and regulatory frameworks — so you can understand exactly how they relate.
What Is A Biosensor?
A biosensor is an analytical device that combines a biological sensing element — such as enzymes, antibodies, or nucleic acids — with a physicochemical detector to convert biological interactions into measurable signals. [1]
The applications of biosensors extend well beyond medicine. Food safety testing, environmental pollutant monitoring, rapid pathogen screening, and DNA analysis all rely on biosensor technology.
Depending on the target analyte, biosensors are classified into several subtypes: glucose biosensors, DNA biosensors, and immunosensors, among others.
Among these, the glucose biosensor is the most commercially developed subtype — and the core detection principle behind modern CGM technology.
What Is A CGM?
Continuous glucose monitoring (CGM) means using a device to automatically estimate blood glucose levels throughout the day and night. [2]
According to the CDC, an estimated 40.1 million people in the United States had diagnosed or undiagnosed diabetes in 2023. [3] The widespread adoption of CGM technology carries significant clinical value for this population.
Today's CGM devices fall into two main categories. Prescription CGMs are intended for people with type 1 diabetes and those with type 2 diabetes who use insulin.
In March 2024, the FDA cleared the first OTC CGM — designed for adults aged 18 and older with type 2 diabetes who do not use insulin, or with prediabetes. [4]
Leading brands offer CGM products across both categories, from prescription-grade to consumer-level monitoring. SIBIONICS CGM focuses on delivering medical-grade continuous glucose monitoring for users in European markets.
Biosensor VS CGM: Key Differences Explained
To truly understand biosensor VS CGM, here is what matters most: CGM is not the opposite of a biosensor. It is a specific application within the biosensor family, optimized for continuous glucose monitoring.
The following table highlights the core differences across five dimensions.
| Dimension | Biosensor (Broad Category) | CGM |
|---|---|---|
| Scope | All bio-sensing devices (general category) | Specialized for continuous glucose monitoring (subcategory) |
| Detection Target | Glucose, DNA, proteins, and other analytes | Glucose concentration only |
| Use Cases | Medicine, food safety, environmental monitoring | Diabetes management, continuous glucose tracking |
| Form Factor | Lab instruments, portable devices, and more | Wearable subcutaneous sensor, worn continuously |
| US Regulation | Varies by intended use | FDA prescription or OTC classification |
How Are They Scientifically Related?
From a scientific classification standpoint, the three terms form a clear hierarchy:
Biosensor (broad category) ⊃ Glucose Biosensor (subcategory) ⊃ CGM Sensor (specific application)
The comparison of glucose biosensor VS CGM is really a comparison between a general technical concept and a specific wearable product optimized for continuous monitoring.
CGM sensors are a real-world engineering implementation of glucose biosensors — one contains the other, rather than the two standing in opposition.
What Makes A CGM Different From A General Glucose Biosensor?
The most popular CGM technique relies on the glucose oxidation reaction: a glucose-oxidase-doped platinum electrode catalyzes glucose oxidation, producing an electrical current that is converted into a glucose reading. [5]
Compared to a general glucose biosensor, CGM is engineered for three specific capabilities: continuity, wearability, and real-time data transmission.
Continuity means automatic sampling every 1 to 5 minutes, around the clock. Wearability means a miniaturized sensor worn subcutaneously for days or weeks. Data transmission sends readings via Bluetooth to a smartphone or receiver.
CGM VS Biosensor: The Regulatory Distinction In The US
In the United States, the key regulatory distinction does not fall between "biosensor" and "CGM" as opposing categories. The real dividing line exists within the CGM classification framework itself — between prescription and OTC devices.
When examining cgm VS biosensor from a regulatory standpoint, there is no formal boundary between the two terms. What actually matters is whether a specific CGM product requires a prescription.
CE-certified CGM devices such as SIBIONICS GS3 are currently sold in the European market and fall outside the FDA's prescription or OTC framework. Understanding a device's regulatory status is essential before purchasing.
Which One Do You Need: Prescription CGM Or OTC Glucose Biosensor?
Identifying your own situation is the first step toward choosing the right device. The framework below can help guide your decision.
| Population | Recommended Path | Typical Products |
|---|---|---|
| People with type 1 diabetes | Prescription CGM | Dexcom G7, FreeStyle Libre 3 |
| People with type 2 diabetes using insulin | Prescription CGM | Dexcom G7, Medtronic Guardian 4 (hybrid closed-loop systems) |
| T2D without insulin or prediabetes (US) | OTC CGM | Dexcom Stelo, Abbott Lingo |
| Users in Europe | CE-certified CGM | SIBIONICS GS3 Sensor |
For users in Europe, CE-certified brands are available through global cgm suppliers.
When evaluating options, pay close attention to sensor wear duration, accuracy metrics (MARD), and app compatibility. Always consult a healthcare professional before choosing a device.
CGM Devices Available Today
The global CGM market now spans the full range of use cases, from prescription-grade clinical devices to consumer-level monitors. Below is a side-by-side comparison of the major products available today.
| Brand | Product | Wear Duration | US Regulatory Status | Target Users |
|---|---|---|---|---|
| Dexcom | G7 | 10 days | FDA prescription | T1D and insulin-using T2D |
| Dexcom | Stelo | 15 days | FDA OTC | T2D without insulin and prediabetes |
| Abbott | FreeStyle Libre 3 | 14 days | FDA prescription | T1D and insulin-using T2D |
| Abbott | Lingo | 14 days | FDA OTC | Wellness and health management users |
| Medtronic | Guardian 4 | 7 days | FDA prescription | T1D/T2D; typically used within hybrid closed-loop insulin delivery systems |
| SIBIONICS | GS3 | 14 days | N/A (CE certified, non-US market) | People with diabetes in Europe |
Leading global cgm supplies providers differ in sensor accuracy, companion app features, and data platform integration.
Consult your healthcare provider and consider your lifestyle and monitoring goals when choosing a device.
Verdict
A biosensor is a broad technical category. CGM is a specific application within it, engineered for continuous glucose monitoring.
The relationship between the two is one of inclusion, not opposition. Every CGM sensor is a glucose biosensor — but not every glucose biosensor is a CGM.
When it comes to choosing a device, the real question is not "biosensor or CGM?" — it's "prescription CGM or OTC CGM, and which market are you in?"
Leading global cgm brands — including CE-certified devices like the SIBIONICS GS3 — offer a range of medical-grade monitoring solutions across markets and clinical scenarios.
FAQ
Q: Is A CGM The Same As A Biosensor?
Not exactly. A CGM is a specific type of glucose biosensor, which is itself a subtype of the broader biosensor category.
Every CGM sensor qualifies as a biosensor — but the biosensor category is far broader, encompassing DNA sensors, immunosensors, and many other types.
Q: What Is The Difference Between A Glucose Biosensor And A CGM?
A glucose biosensor is a general technical concept referring to any bio-sensing device designed to detect glucose, including the sensing element inside a traditional fingerstick meter.
A CGM is a specific product implementation of glucose biosensor technology for wearable medical devices, defined by continuous sampling, a subcutaneous wearable design, and real-time data transmission.
Q: Do I Need A Prescription For A CGM?
In the United States, it depends on the specific product. People with diabetes who use insulin typically require a prescription CGM.
In 2024, the FDA cleared the first OTC CGM for adults with type 2 diabetes who do not use insulin, or with prediabetes — no prescription needed.
In other countries, regulatory requirements vary. Consult a local healthcare professional for guidance.
Q: How Does A CGM Biosensor Work?
Most CGM sensors use an electrochemical principle based on glucose oxidase. A platinum electrode reacts with glucose oxidase to convert glucose concentration into an electrical current.
The CGM device then translates that current into a real-time blood glucose reading, which is transmitted via Bluetooth to a smartphone or receiver.
Q: Can A Biosensor Replace Traditional Blood Glucose Testing?
For most day-to-day diabetes management, CGM biosensors provide accurate continuous data as the primary reference.
However, in certain clinical decisions — such as adjusting insulin doses — some devices may still require fingerstick blood glucose verification under specific circumstances.
Before using any CGM device, discuss your monitoring plan with your doctor to determine the approach best suited to your individual needs.
References
[1] ACS Omega. (December 2024). Biosensor review. https://pmc.ncbi.nlm.nih.gov/articles/PMC11656264/
[2] National Institute of Diabetes and Digestive and Kidney Diseases. (June 2023). Continuous Glucose Monitoring. https://www.niddk.nih.gov/health-information/diabetes/overview/managing-diabetes/continuous-glucose-monitoring
[3] Centers for Disease Control and Prevention. (January 2026). Diabetes Data and Statistics. https://www.cdc.gov/diabetes/php/data-research/index.html
[4] Yale Medicine. (November 15, 2024). Continuous Glucose Monitor. https://www.yalemedicine.org/news/continuous-glucose-monitor
[5] Diabetes & Metabolism Journal. (July 2019). Continuous glucose monitoring. https://pmc.ncbi.nlm.nih.gov/articles/PMC6712232/
Disclaimer
This article is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
Author Information
This article was written by the SIBIONICS Professional Health Content Team. Our writers draw on peer-reviewed literature and authoritative institutional guidelines to deliver accurate, science-based information about CGM and biosensor technology.
Last Updated: April 28, 2026
